Milestone Scientific Inc. has secured $2.1 million in funding from investors. The company is dedicated to advancing computer-controlled drug delivery systems designed to enhance efficiency and patient comfort across the medical and dentistry sectors. Milestone Scientific aims to redefine the global standard of care in anesthesia by making the experience more comfortable for patients and reducing stress for healthcare providers during injections, moving beyond the limitations of traditional methods.
Central to Milestone Scientific's offerings is its revolutionary DPS Dynamic Pressure Sensing Technology®. This innovative technology addresses the requirements of various subcutaneous drug delivery injections and fluid aspiration, providing healthcare practitioners with multiple unique benefits not achievable with traditional 160-year-old manual syringes. The company's product portfolio includes the CompuFlo® Epidural for epidural injections, CathCheck for epidural catheter verification, CompuFlo® Intra-Articular for intra-articular injections, and The Wand®, a widely recognized computer-assisted system for local dental anesthesia. These instruments enable doctors and dentists to mitigate complications and waste often associated with manual injection methods, thereby improving procedural safety and precision.
This capital infusion marks a significant step for Milestone Scientific Inc., providing crucial resources for its strategic objectives. The $2.1 million raised will be strategically deployed to support the company's ongoing growth initiatives, including potential market expansion and further development of its innovative drug delivery platforms. The investment underscores confidence in Milestone Scientific's mission to modernize injection procedures and improve patient outcomes globally. The company plans to continue expanding the adoption of its next-generation medical and dental instruments, reinforcing its position as a leader in advanced drug delivery technology and enhancing the standard of care worldwide.
